{
  "run_id": "RUN_20260205_073751_f71574fffb78",
  "timestamp": "2026-02-05T09:21:43.223196",
  "document": "Leukodystrophy.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/NLP4RARE/dev/Leukodystrophy.pdf",
  "pipeline_version": "0.8",
  "total_recommendation_sets": 1,
  "total_recommendations": 5,
  "recommendation_sets": [
    {
      "guideline_name": "Not specified",
      "guideline_year": null,
      "organization": "NORD",
      "target_condition": "leukodystrophies",
      "target_population": null,
      "recommendations": [
        {
          "recommendation_id": "rec_Leukodystrophy_1",
          "recommendation_type": "treatment",
          "population": "patients with leukodystrophies",
          "condition": "symptomatic leukodystrophy",
          "severity": "not specified",
          "action": "provide symptomatic and supportive treatment",
          "action_description": null,
          "preferred": "not specified",
          "alternatives": [],
          "dosing": [],
          "taper_target": "not specified",
          "duration": "not specified",
          "stop_window": null,
          "evidence_level": "expert_opinion",
          "strength": "conditional",
          "references": [],
          "source": "Leukodystrophy",
          "source_text": "Treatment of most leukodystrophies is symptomatic and supportive",
          "page_num": null
        },
        {
          "recommendation_id": "rec_Leukodystrophy_2",
          "recommendation_type": "treatment",
          "population": "patients with leukodystrophies with spasticity and motor difficulties",
          "condition": "spasticity and motor difficulties",
          "severity": "not specified",
          "action": "provide medications and physical therapy",
          "action_description": null,
          "preferred": "not specified",
          "alternatives": [],
          "dosing": [],
          "taper_target": "not specified",
          "duration": "not specified",
          "stop_window": null,
          "evidence_level": "expert_opinion",
          "strength": "weak",
          "references": [],
          "source": "Leukodystrophy",
          "source_text": "Medications and physical therapy may be helpful for spasticity and motor difficulties",
          "page_num": null
        },
        {
          "recommendation_id": "rec_Leukodystrophy_3",
          "recommendation_type": "treatment",
          "population": "patients with leukodystrophies with seizures",
          "condition": "seizures",
          "severity": "not specified",
          "action": "provide anti-epileptic medications",
          "action_description": null,
          "preferred": "not specified",
          "alternatives": [],
          "dosing": [],
          "taper_target": "not specified",
          "duration": "not specified",
          "stop_window": null,
          "evidence_level": "expert_opinion",
          "strength": "conditional",
          "references": [],
          "source": "Leukodystrophy",
          "source_text": "Anti-epileptic medications should be provided for seizures",
          "page_num": null
        },
        {
          "recommendation_id": "rec_Leukodystrophy_4",
          "recommendation_type": "treatment",
          "population": "patients with leukodystrophies with burning paresthesia from peripheral neuropathy",
          "condition": "neuropathic pain",
          "severity": "not specified",
          "action": "provide medications for neuropathic pain",
          "action_description": null,
          "preferred": "not specified",
          "alternatives": [],
          "dosing": [],
          "taper_target": "not specified",
          "duration": "not specified",
          "stop_window": null,
          "evidence_level": "expert_opinion",
          "strength": "weak",
          "references": [],
          "source": "Leukodystrophy",
          "source_text": "burning paresthesia from peripheral neuropathy may respond to medications for neuropathic pain",
          "page_num": null
        },
        {
          "recommendation_id": "rec_Leukodystrophy_5",
          "recommendation_type": "treatment",
          "population": "affected individuals and their families",
          "condition": "leukodystrophy",
          "severity": "not specified",
          "action": "provide genetic counseling",
          "action_description": null,
          "preferred": "not specified",
          "alternatives": [],
          "dosing": [],
          "taper_target": "not specified",
          "duration": "not specified",
          "stop_window": null,
          "evidence_level": "expert_opinion",
          "strength": "conditional",
          "references": [],
          "source": "Leukodystrophy",
          "source_text": "Genetic counseling is beneficial for affected individuals and their families",
          "page_num": null
        }
      ],
      "source_document": "Leukodystrophy",
      "extraction_confidence": 0.85
    }
  ]
}